Treatment of lateralisation and subluxation of the hip in cerebral palsy with Botulinum toxin A: preliminary results based on the analysis of migration percentage data.
Standard
Treatment of lateralisation and subluxation of the hip in cerebral palsy with Botulinum toxin A: preliminary results based on the analysis of migration percentage data. / Placzek, R; Deuretzbacher, Georg; Meiss, A L.
In: NEUROPEDIATRICS, Vol. 35, No. 1, 1, 2004, p. 6-9.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Treatment of lateralisation and subluxation of the hip in cerebral palsy with Botulinum toxin A: preliminary results based on the analysis of migration percentage data.
AU - Placzek, R
AU - Deuretzbacher, Georg
AU - Meiss, A L
PY - 2004
Y1 - 2004
N2 - It has been reported that cerebral palsy patients with adductor spasm and lateralisation/subluxation of the hip can be treated with Botulinum toxin A, but statistical evaluation is lacking. We present the radiological results in 5 patients. The follow-up ranged from 18 (5 patients) to 24 months (4 patients). Reimers' migration percentage was chosen as parameter for lateralisation/subluxation. Statistical analysis was performed by the Wilcoxon test. The migration percentage improved from 51% to 44% at 9 months, 37% at 18 months, and 34% at 24 months. The improvement was significant from the 9th to the 18th month (p=0.04).
AB - It has been reported that cerebral palsy patients with adductor spasm and lateralisation/subluxation of the hip can be treated with Botulinum toxin A, but statistical evaluation is lacking. We present the radiological results in 5 patients. The follow-up ranged from 18 (5 patients) to 24 months (4 patients). Reimers' migration percentage was chosen as parameter for lateralisation/subluxation. Statistical analysis was performed by the Wilcoxon test. The migration percentage improved from 51% to 44% at 9 months, 37% at 18 months, and 34% at 24 months. The improvement was significant from the 9th to the 18th month (p=0.04).
M3 - SCORING: Zeitschriftenaufsatz
VL - 35
SP - 6
EP - 9
JO - NEUROPEDIATRICS
JF - NEUROPEDIATRICS
SN - 0174-304X
IS - 1
M1 - 1
ER -